Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery

Neurosurgery

Volumn 59, Issue 1, 2006, Pages 86-95

  Truong, Minh T ^a,d   St Clair, Eric G ^b   Donahue, Bernadine R ^b   Rush, Stephen C ^c   Miller, Douglas C ^b   Formenti, Silvia C ^b   Knopp, Edmond A ^b   Han, Kerry ^b   Golfinos, John G ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Long Island Radiation Therapy   (United States)

^d BOSTON MEDICAL CENTER   (United States)

Author keywords

Brain metastases; Dynamic contrast enhanced perfusion magnetic resonance imaging; Magnetic resonance spectroscopy; Radiosurgery; Salvage therapy; Treatment outcome

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN SURGERY; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GAMMA KNIFE RADIOSURGERY; HEMIPARESIS; HUMAN; HUMAN TISSUE; MALE; MEDICAL DECISION MAKING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION NECROSIS; SCORING SYSTEM; TREATMENT OUTCOME; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COHORT STUDIES; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PROGNOSIS; RADIOSURGERY; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33745775912     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000219858.80351.38     Document Type: Article

References (33)

1. Alexander E, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, Kooy HM, Loeffler JS: Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87:34-40, 1995.
2. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet 363:1665-1672, 2004.
3. Antonadou D, Paraskevaidis M, Sarris G, Coliarakis N, Economou I, Karageorgis P, Throuvalas N: Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 20:3644-3650, 2002.
4. Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, Kuter I, Bunnell C, Rue M, Gelman R, Winer E: Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 97:2972-2977, 2003.
5. Borgelt B, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, Perez CA, Hendrickson FR: The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6:1-9, 1980.
6. DeAngelis LM, Delattre JY, Posner JB: Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789-796, 1989.
7. de Crevoisier R, Pierga JY, Dendale R, Feuvret L, Noel G, Simon JM, Mazeron JJ: Radiotherapy of glioblastoma. Cancer Radiother 1:194-207, 1997.
8. Donahue BR, Goldberg JD, Golfinos JG, Knopp EA, Comiskey J, Rush SC, Han K, Mukhi V, Cooper JS: Importance of MR technique for stereotactic radiosurgery. Neuro-oncology 5:268-274, 2003.
9. Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, Hudgins WR, Weiner R, Harsh GR 4th, Sneed PK, Larson DA: A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28:797-802, 1994.
10. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745-751, 1997.
11. Johnson JD, Young B: Demographics of brain metastasis. Neurosurg Clin North Am 7:337-344, 1996.
12. Kimura T, Sako K, Tohyama Y, Aizawa S, Yoshida H, Aburano T, Tanaka K, Tanaka T: Diagnosis and treatment of progressive space-occupying radiation necrosis following stereotactic radiosurgery for brain metastasis: Value of proton magnetic resonance spectroscopy. Acta Neurochir (Wien) 145: 557-564, 2003.
13. Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, Miller DC, Kelly PJ, Kricheff 2nd: Glial neoplasms: Dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211:791-798, 1999.
14. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW: High-grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715-721, 2002.
15. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D: Glioma grading: Sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989-1998, 2003.
16. Lin AP, Ross BD: Short-echo time proton MR spectroscopy in the presence of gadolinium. J Comput Assist Tomogr 25:705-712, 2001.
17. Murphy PS, Dzik-Jurasz AS, Leach MO, Rowland IJ: The effect of Gd-DTPA on T(1)-weighted choline signal in human brain tumours. Magn Reson Imaging 20:127-130, 2002.
18. Omuro AM, Kris MG, Miller VA, Franceschi E, Shah N, Milton DT, Abrey LE: High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib. Cancer 103:2344-2348, 2005.
19. Paek SH, Audu PB, Sperling MR, Cho J, Andrews DW: Reevaluation of surgery for the treatment of brain metastases: Review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 56:1021-1034, 2005.
20. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494-500, 1990.
21. Sanghavi SN, Miranpuri SS, Chappell R, Buatti JM, Sneed PK, Suh JH, Regine WF, Weltman E, King VJ, Goetsch SJ, Breneman JC, Sperduto PW, Scott C, Mabanta S, Mehta MP: Radiosurgery for patients with brain metastases: A multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 51:426-434, 2001.
22. Shaw EG: Radiotherapeutic management of multiple brain metastases: "3000 in 10" whole brain radiation is no longer a "no brainer." Int J Radiat Oncol Biol Phys 45:253-254, 1999.
23. Shaw E, Scott C, Souhami L, Dinapoli R, Bahary JP, Kline R, Wharam M, Schultz C, Davey P, Loeffler J, Del Rowe J, Marks L, Fisher B, Shin K: Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: Initial report of radiation therapy oncology group protocol (90-05). Int J Radiat Oncol Biol Phys 34:647-654, 1996.
24. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47:291-298, 2000.
25. Smith JK, Kwock L, Castillo M: Effects of contrast material on single-volume proton MR spectroscopy. AJNR Am J Neuroradiol 21:1084-1089, 2000.
26. Sneed PK, Lamborn KR, Forstner JM, McDermott MW, Chang S, Park E, Gutin PH, Phillips TL, Wara WM, Larson DA: Radiosurgery for brain metastases: Is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43:549-558, 1999.
27. Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM, Regine WF, Weltman E, King VJ, Breneman JC, Sperduto PW, Mehta MP: A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519-526, 2002.
28. Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar AK, Kondziolka D, Lunsford LD: Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 57:452-464, 2003.
29. Vecht CJ, Haaxma-Reiche H, Noordijk EM, Padberg GW, Voormolen JH, Hoekstra FH, Tans JT, Lambooij N, Metsaars JA, Wattendorff AR, Brand R, Hermans J: Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery? Ann Neurol 33:583-590, 1993.
30. Vecil GG, Suki D, Maldaun MV, Lang FF, Sawaya R: Resection of brain metastases previously treated with stereotactic radiosurgery. J Neurosurg 102:209-215, 2005.
31. Weber MA, Lichy MP, Thilmann C, Gunther M, Bachert P, Maudsley AA, Delorme S, Schad LR, Debus J, Schlemmer HP: Monitoring of irradiated brain metastases using MR perfusion imaging and 1H MR spectroscopy. Radiologe 43:388-395, 2003.
32. Weber MA, Thilmann C, Lichy MP, Gunther M, Delorme S, Zuna I, Bongers A, Schad LR, Debus J, Kauczor HU, Essig M, Schlemmer HP: Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: Initial results. Invest Radiol 39:277-287, 2004.
33. Wetzel SG, Cha S, Johnson G, Lee P, Law M, Kasow DL, Pierce SD, Xue X: Relative cerebral blood volume measurements in intracranial mass lesions: Interobserver and intraobserver reproducibility study. Radiology 224:797-803, 2002.